BioAdaptives, Inc. (BDPT) stock
BDPTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00−0.00 (-5.56%)
Close on Oct 19, 2026Market cap $478.03KP/E –Yield –
BioAdaptives operating margin
Operating margin is operating income as a percentage of revenue.
BioAdaptives's operating margin for the twelve months ending Jun 30, 2026 was -3557.0%. For fiscal 2025 it was -5701.8%, against -4752.5% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -5701.8% | −949.3 |
| FY2024 | Dec 31, 2024 | -4752.5% | −3951.1 |
| FY2023 | Dec 31, 2023 | -801.4% | +1654.9 |
| FY2022 | Dec 31, 2022 | -2456.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -3953.0% | +4721.1 |
| Q1 FY2026 | Mar 31, 2026 | -3594.8% | +10179.7 |
| Q4 FY2025 | Dec 31, 2025 | -2379.6% | −1964.1 |
| Q3 FY2025 | Sep 30, 2025 | -5735.9% | −4878.0 |
| Q2 FY2025 | Jun 30, 2025 | -8674.1% | −8084.8 |
| Q2 FY2024 | Jun 30, 2024 | -13774.5% | −11382.5 |
| Q1 FY2024 | Mar 31, 2024 | -415.5% | +146.6 |
| Q4 FY2023 | Dec 31, 2023 | -858.0% | −637.7 |
| Q3 FY2023 | Sep 30, 2023 | -589.3% | – |
| Q2 FY2023 | Jun 30, 2023 | -2392.0% | – |
| Q1 FY2023 | Mar 31, 2023 | -562.1% | – |
| Q3 FY2016 | Sep 30, 2016 | -220.3% | – |
See a number that looks wrong?